Rockefeller Capital Management’s Immunic IMUX Stock Holding History
Bought
Maintained
Sold
Other funds holding IMUX
APM
BI
VCM
SCM
LCM
NCM
6CM
Rockefeller Capital Management's IMUX Position: Q1 2026 in Review
Rockefeller Capital Management held its Immunic (IMUX) position steady in Q1 2026 at 100 shares worth $1.11K. The position accounts for ﹤0.01% of the portfolio, ranked #4474.
Rockefeller Capital Management first reported a position in IMUX in Q3 2025 and has held it in 3 quarters since. 75 funds tracked by Wall St. Rank hold IMUX as of Q1 2026.
- Rockefeller Capital Management held 100 shares of Immunic worth $1.11K as of Q1 2026.
- Rockefeller Capital Management left its Immunic share count unchanged in Q1 2026.
- Immunic made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4474 holding.
- Rockefeller Capital Management first reported a position in Immunic in Q3 2025 and has held it in 3 quarters since.
- 75 funds tracked by Wall St. Rank held Immunic as of Q1 2026.
Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.